首页 > 最新文献

World Journal of Surgical Oncology最新文献

英文 中文
Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma 在复发性或转移性头颈部鳞状细胞癌患者中,低蛋白血症和高钙血症与抗PD-1免疫检查点抑制剂的不良治疗效果独立相关
IF 3.2 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-11 DOI: 10.1186/s12957-024-03522-2
Tai-Jan Chiu, Tai-Lin Huang, Chih-Yen Chien, Wan-Ting Huang, Shau-Hsuan Li
Recent randomized phase III trials have demonstrated the efficacy of anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICIs) in treating patients with recurrent or metastatic head and neck squamous cell carcinoma (RMHNSCC). However, a large proportion of such patients still have poor response. This study aimed to identify biomarkers for predicting anti-PD-1 ICI treatment outcomes . We retrospectively analyzed 144 patients with RMHNSCC who received anti-PD-1 ICIs after progression to platinum-based chemotherapy between January 2017 and December 2022 at Kaohsiung Chang Gung Memorial Hospital. Data on clinicopathological parameters, albumin levels, calcium levels, and other pretreatment peripheral blood biomarkers, including total lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and prognostic nutritional index (PNI) were collected and correlated with the treatment outcome of anti-PD-1 ICIs. Low tumor proportion score (TPS), low combined positive score (CPS), NLR ≥ 5, PLR ≥ 300, hypercalcemia, hypoalbuminemia, and PNI < 45 were significantly correlated with poor response of ICIs. The overall response rates were 25% and 3% in patients with calcium < 10 mg/dL and calcium ≥ 10 mg/dL, respectively (P = 0.007). The overall response rates were 6% and 33% in patients with albumin < 4 g/dL and albumin ≥ 4 g/dL, respectively (P < 0.001). Univariate survival analysis showed that low TPS, low CPS, NLR ≥ 5,, hypercalcemia, hypoalbuminemia, and PNI < 45 were significantly associated with worse progression-free survival (PFS) and inferior overall survival (OS). Multivariate analysis revealed that calcium ≥ 10 mg/dL and albumin < 4 g/dL were independent poor prognosticators for worse PFS and inferior OS. The two-year OS rates were 26% and 9% in patients with calcium < 10 mg/dL and ≥ 10 mg/dL, respectively (P < 0.001). The two-year OS rates were 10% and 33% in patients with albumin < 4 g/dL and ≥ 4 g/dL, respectively (P < 0.001). Hypercalcemia and hypoalbuminemia can potentially predict poor treatment outcomes of anti-PD-1 ICIs in patients with RMHNSCC. Blood calcium and albumin levels may be helpful in individualizing treatment strategies for patients with RMHNSCC.
最近的随机III期试验证明,抗程序性细胞死亡1(PD-1)免疫检查点抑制剂(ICIs)在治疗复发性或转移性头颈部鳞状细胞癌(RMHNSCC)患者方面疗效显著。然而,很大一部分此类患者的反应仍然不佳。本研究旨在确定预测抗PD-1 ICI治疗结果的生物标志物。我们回顾性分析了2017年1月至2022年12月期间在高雄长庚纪念医院接受铂类化疗进展后接受抗PD-1 ICIs治疗的144例RMHNSCC患者。研究人员收集了临床病理参数、白蛋白水平、血钙水平以及其他治疗前外周血生物标志物的数据,包括淋巴细胞总数、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)和预后营养指数(PNI),并将这些数据与抗PD-1 ICIs的治疗结果进行了相关分析。低肿瘤比例评分(TPS)、低综合阳性评分(CPS)、NLR≥5、PLR≥300、高钙血症、低白蛋白血症和PNI<45与ICIs的不良反应显著相关。血钙<10 mg/dL和血钙≥10 mg/dL患者的总反应率分别为25%和3%(P = 0.007)。白蛋白<4 g/dL和白蛋白≥4 g/dL患者的总反应率分别为6%和33%(P<0.001)。单变量生存分析显示,低TPS、低CPS、NLR≥5、高钙血症、低白蛋白血症和PNI<45与较差的无进展生存期(PFS)和较差的总生存期(OS)显著相关。多变量分析显示,血钙≥10 mg/dL和白蛋白<4 g/dL是导致无进展生存期缩短和OS降低的独立不良预后指标。血钙<10 mg/dL和≥10 mg/dL患者的两年OS率分别为26%和9%(P<0.001)。白蛋白<4 g/dL和≥4 g/dL的患者两年的OS率分别为10%和33%(P<0.001)。高钙血症和低白蛋白血症可能预示着RMHNSCC患者使用抗PD-1 ICIs治疗效果不佳。血钙和白蛋白水平可能有助于为RMHNSCC患者制定个体化治疗策略。
{"title":"Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma","authors":"Tai-Jan Chiu, Tai-Lin Huang, Chih-Yen Chien, Wan-Ting Huang, Shau-Hsuan Li","doi":"10.1186/s12957-024-03522-2","DOIUrl":"https://doi.org/10.1186/s12957-024-03522-2","url":null,"abstract":"Recent randomized phase III trials have demonstrated the efficacy of anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICIs) in treating patients with recurrent or metastatic head and neck squamous cell carcinoma (RMHNSCC). However, a large proportion of such patients still have poor response. This study aimed to identify biomarkers for predicting anti-PD-1 ICI treatment outcomes . We retrospectively analyzed 144 patients with RMHNSCC who received anti-PD-1 ICIs after progression to platinum-based chemotherapy between January 2017 and December 2022 at Kaohsiung Chang Gung Memorial Hospital. Data on clinicopathological parameters, albumin levels, calcium levels, and other pretreatment peripheral blood biomarkers, including total lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and prognostic nutritional index (PNI) were collected and correlated with the treatment outcome of anti-PD-1 ICIs. Low tumor proportion score (TPS), low combined positive score (CPS), NLR ≥ 5, PLR ≥ 300, hypercalcemia, hypoalbuminemia, and PNI < 45 were significantly correlated with poor response of ICIs. The overall response rates were 25% and 3% in patients with calcium < 10 mg/dL and calcium ≥ 10 mg/dL, respectively (P = 0.007). The overall response rates were 6% and 33% in patients with albumin < 4 g/dL and albumin ≥ 4 g/dL, respectively (P < 0.001). Univariate survival analysis showed that low TPS, low CPS, NLR ≥ 5,, hypercalcemia, hypoalbuminemia, and PNI < 45 were significantly associated with worse progression-free survival (PFS) and inferior overall survival (OS). Multivariate analysis revealed that calcium ≥ 10 mg/dL and albumin < 4 g/dL were independent poor prognosticators for worse PFS and inferior OS. The two-year OS rates were 26% and 9% in patients with calcium < 10 mg/dL and ≥ 10 mg/dL, respectively (P < 0.001). The two-year OS rates were 10% and 33% in patients with albumin < 4 g/dL and ≥ 4 g/dL, respectively (P < 0.001). Hypercalcemia and hypoalbuminemia can potentially predict poor treatment outcomes of anti-PD-1 ICIs in patients with RMHNSCC. Blood calcium and albumin levels may be helpful in individualizing treatment strategies for patients with RMHNSCC.","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142183841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Androgen receptor expression and clinical characteristics in breast cancer 乳腺癌中雄激素受体的表达和临床特征
IF 3.2 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-11 DOI: 10.1186/s12957-024-03525-z
Dan-dan Wang, Lin-hong Jiang, Jian Zhang, Xiu Chen, Hong-lei Zhou, Shan-liang Zhong, He-da Zhang
To investigate the relationship between the expression of androgen receptor (AR) and clinical characteristics in breast cancer. The clinical records of all 432 patients tested for AR in our institution between January 2020 and May 2023 were reviewed. Clinical characteristics, age, menopausal status, tumor node metastasis (TNM) stage, distant metastasis, pathological complete response (pCR), histopathological features histological grade, estrogen receptor (ER), progesterone receptor, Her-2, Ki-67, and molecular subtype were registered for all patients. About 377 (87.27%) of the 432 patients had AR expression. No significant difference in AR expression was found with age, menopausal status, TNM stage of primary tumor, or pCR. AR was positively and significantly associated with the histological grade, and recurrence. The AR expression was significantly related with molecular subtypes, including ER, PR Her-2, Ki67 and molecular subtype. ER (OR = 10.489, 95%CI: 5.470–21.569), PR (OR = 7.690, 95%CI: 3.974–16.129, Her-2 (OR = 10.489, 95%CI: 2.779–23.490 and tumor recurrence (OR = 0.110, 95%CI: 0.031–0.377 were significant independent risk factors affecting AR expression. AR expression can serve as a reliable basis for judging the clinical molecular types and poor prognosis for breast cancer. AR may be a novel biomarker and target in AR-positive breast cancer depending on significant difference in AR expression among different molecular types of breast cancer.
目的 研究乳腺癌中雄激素受体(AR)的表达与临床特征之间的关系。回顾2020年1月至2023年5月期间在我院接受AR检测的所有432名患者的临床记录。对所有患者的临床特征、年龄、绝经状态、肿瘤结节转移(TNM)分期、远处转移、病理完全反应(pCR)、组织病理学特征组织学分级、雌激素受体(ER)、孕激素受体、Her-2、Ki-67和分子亚型进行了登记。432 例患者中约有 377 例(87.27%)有 AR 表达。AR表达与年龄、绝经状态、原发肿瘤的TNM分期或pCR无明显差异。AR与组织学分级和复发呈显著正相关。AR的表达与分子亚型(包括ER、PR Her-2、Ki67和分子亚型)明显相关。ER(OR=10.489,95%CI:5.470-21.569)、PR(OR=7.690,95%CI:3.974-16.129)、Her-2(OR=10.489,95%CI:2.779-23.490)和肿瘤复发(OR=0.110,95%CI:0.031-0.377)是影响AR表达的重要独立危险因素。AR表达可作为判断乳腺癌临床分子类型和不良预后的可靠依据。根据不同分子类型乳腺癌中AR表达的显著差异,AR可能是AR阳性乳腺癌的新型生物标志物和靶点。
{"title":"Androgen receptor expression and clinical characteristics in breast cancer","authors":"Dan-dan Wang, Lin-hong Jiang, Jian Zhang, Xiu Chen, Hong-lei Zhou, Shan-liang Zhong, He-da Zhang","doi":"10.1186/s12957-024-03525-z","DOIUrl":"https://doi.org/10.1186/s12957-024-03525-z","url":null,"abstract":"To investigate the relationship between the expression of androgen receptor (AR) and clinical characteristics in breast cancer. The clinical records of all 432 patients tested for AR in our institution between January 2020 and May 2023 were reviewed. Clinical characteristics, age, menopausal status, tumor node metastasis (TNM) stage, distant metastasis, pathological complete response (pCR), histopathological features histological grade, estrogen receptor (ER), progesterone receptor, Her-2, Ki-67, and molecular subtype were registered for all patients. About 377 (87.27%) of the 432 patients had AR expression. No significant difference in AR expression was found with age, menopausal status, TNM stage of primary tumor, or pCR. AR was positively and significantly associated with the histological grade, and recurrence. The AR expression was significantly related with molecular subtypes, including ER, PR Her-2, Ki67 and molecular subtype. ER (OR = 10.489, 95%CI: 5.470–21.569), PR (OR = 7.690, 95%CI: 3.974–16.129, Her-2 (OR = 10.489, 95%CI: 2.779–23.490 and tumor recurrence (OR = 0.110, 95%CI: 0.031–0.377 were significant independent risk factors affecting AR expression. AR expression can serve as a reliable basis for judging the clinical molecular types and poor prognosis for breast cancer. AR may be a novel biomarker and target in AR-positive breast cancer depending on significant difference in AR expression among different molecular types of breast cancer.","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142183852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel nomogram based on the number of positive lymph nodes can predict the overall survival of patients with pancreatic head cancer after radical surgery. 基于阳性淋巴结数量的新型提名图可以预测胰头癌患者根治术后的总生存期。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-09 DOI: 10.1186/s12957-024-03519-x
Ke You, Kai Lei, Xingxing Wang, Run Hu, Huizhi Zhang, Jie Xu, Zuojin Liu

Background: This study aimed to construct a novel nomogram based on the number of positive lymph nodes to predict the overall survival of patients with pancreatic head cancer after radical surgery.

Materials and methods: 2271 and 973 patients in the SEER Database were included in the development set and validation set, respectively. The primary clinical endpoint was OS (overall survival). Univariate and multivariate Cox regression analyses were used to screen independent risk factors of OS, and then independent risk factors were used to construct a novel nomogram. The C-index, calibration curves, and decision analysis curves were used to evaluate the predictive power of the nomogram in the development and validation sets.

Results: After multivariate Cox regression analysis, the independent risk factors for OS included age, tumor extent, chemotherapy, tumor size, LN (lymph nodes) examined, and LN positive. A nomogram was constructed by using independent risk factors for OS. The C-index of the nomogram for OS was 0.652 [(95% confidence interval (CI): 0.639-0.666)] and 0.661 (95%CI: 0.641-0.680) in the development and validation sets, respectively. The calibration curves and decision analysis curves proved that the nomogram had good predictive ability.

Conclusions: The nomogram based on the number of positive LN can effectively predict the overall survival of patients with pancreatic head cancer after surgery.

背景:本研究旨在构建一个基于阳性淋巴结数量的新型提名图,以预测胰头癌患者根治术后的总生存期。材料与方法:SEER数据库中的2271例和973例患者分别被纳入开发集和验证集。主要临床终点是OS(总生存期)。采用单变量和多变量Cox回归分析筛选OS的独立风险因素,然后利用独立风险因素构建新的提名图。C指数、校准曲线和决策分析曲线用于评估开发集和验证集中提名图的预测能力:经过多变量考克斯回归分析,OS的独立风险因素包括年龄、肿瘤范围、化疗、肿瘤大小、LN(淋巴结)检查和LN阳性。利用OS的独立风险因素构建了一个提名图。在开发集和验证集中,OS提名图的C指数分别为0.652[(95%置信区间(CI):0.639-0.666)]和0.661(95%CI:0.641-0.680)。校准曲线和决策分析曲线证明,提名图具有良好的预测能力:基于LN阳性数量的提名图能有效预测胰头癌患者术后的总生存率。
{"title":"A novel nomogram based on the number of positive lymph nodes can predict the overall survival of patients with pancreatic head cancer after radical surgery.","authors":"Ke You, Kai Lei, Xingxing Wang, Run Hu, Huizhi Zhang, Jie Xu, Zuojin Liu","doi":"10.1186/s12957-024-03519-x","DOIUrl":"https://doi.org/10.1186/s12957-024-03519-x","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to construct a novel nomogram based on the number of positive lymph nodes to predict the overall survival of patients with pancreatic head cancer after radical surgery.</p><p><strong>Materials and methods: </strong>2271 and 973 patients in the SEER Database were included in the development set and validation set, respectively. The primary clinical endpoint was OS (overall survival). Univariate and multivariate Cox regression analyses were used to screen independent risk factors of OS, and then independent risk factors were used to construct a novel nomogram. The C-index, calibration curves, and decision analysis curves were used to evaluate the predictive power of the nomogram in the development and validation sets.</p><p><strong>Results: </strong>After multivariate Cox regression analysis, the independent risk factors for OS included age, tumor extent, chemotherapy, tumor size, LN (lymph nodes) examined, and LN positive. A nomogram was constructed by using independent risk factors for OS. The C-index of the nomogram for OS was 0.652 [(95% confidence interval (CI): 0.639-0.666)] and 0.661 (95%CI: 0.641-0.680) in the development and validation sets, respectively. The calibration curves and decision analysis curves proved that the nomogram had good predictive ability.</p><p><strong>Conclusions: </strong>The nomogram based on the number of positive LN can effectively predict the overall survival of patients with pancreatic head cancer after surgery.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study. 利用 ADV 评分早期识别复发风险高的肝细胞癌患者:一项多中心回顾性研究。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-07 DOI: 10.1186/s12957-024-03523-1
Shuya Cao, Zheyu Zhou, Chaobo Chen, Wenwen Li, Jinsong Liu, Jiawei Xu, Chunlong Zhao, Yihang Yuan, Zhenggang Xu, Huaiyu Wu, Guwei Ji, Xiaoliang Xu, Ke Wang

Background: Postoperative recurrence is a vital reason for poor 5-year overall survival in hepatocellular carcinoma (HCC) patients. The ADV score is considered a parameter that can quantify HCC aggressiveness. This study aimed to identify HCC patients at high-risk of recurrence early using the ADV score.

Methods: The medical data of consecutive HCC patients undergoing hepatectomy from The First Affiliated Hospital of Nanjing Medical University (TFAHNJMU) and Nanjing Drum Tower Hospital (NJDTH) were retrospectively reviewed. Based on the status of microvascular invasion and the Edmondson-Steiner grade, HCC patients were divided into three groups: low-risk group (group 1: no risk factor exists), medium-risk group (group 2: one risk factor exists), and high-risk group (group 3: coexistence of two risk factors). In the training cohort (TFAHNJMU), the R package nnet was used to establish a multi-categorical unordered logistic regression model based on the ADV score to predict three risk groups. The Welch's T-test was used to compare differences in clinical variables in three predicted risk groups. NJDTH served as an external validation center. At last, the confusion matrix was developed using the R package caret to evaluate the diagnostic performance of the model.

Results: 350 and 405 patients from TFAHNJMU and NJDTH were included. HCC patients in different risk groups had significantly different liver function and inflammation levels. Density maps demonstrated that the ADV score could best differentiate between the three risk groups. The probability curve was plotted according to the predicted results of the multi-categorical unordered logistic regression model, and the best cut-off values of the ADV score were as follows: low-risk ≤ 3.4 log, 3.4 log < medium-risk ≤ 5.7 log, and high-risk > 5.7 log. The sensitivities of the ADV score predicting the high-risk group (group 3) were 70.2% (99/141) and 78.8% (63/80) in the training and external validation cohort, respectively.

Conclusion: The ADV score might become a valuable marker for screening patients at high-risk of HCC recurrence with a cut-off value of 5.7 log, which might help surgeons, pathologists, and HCC patients make appropriate clinical decisions.

背景:术后复发是导致肝细胞癌(HCC)患者 5 年总生存率低下的重要原因。ADV评分被认为是一个可以量化HCC侵袭性的参数。本研究旨在利用 ADV 评分早期识别高复发风险的 HCC 患者:方法:回顾性分析南京医科大学第一附属医院(TFAHNJMU)和南京鼓楼医院(NJDTH)连续接受肝切除术的HCC患者的医疗资料。根据微血管侵犯情况和Edmondson-Steiner分级,HCC患者被分为三组:低危组(第1组:无危险因素)、中危组(第2组:存在一个危险因素)和高危组(第3组:同时存在两个危险因素)。在训练队列(TFAHNJMU)中,使用 R 软件包 nnet 建立了基于 ADV 评分的多类别无序逻辑回归模型,以预测三个风险组别。韦尔奇 T 检验用于比较三个预测风险组的临床变量差异。南京邮电大学作为外部验证中心。最后,使用R软件包caret开发了混淆矩阵,以评估模型的诊断性能:结果:分别有 350 名和 405 名来自全军医大学和南京大屠杀纪念馆的患者被纳入模型。不同风险组别的 HCC 患者的肝功能和炎症水平明显不同。密度图显示,ADV 评分最能区分三个风险组。根据多分类无序逻辑回归模型的预测结果绘制了概率曲线,ADV评分的最佳临界值如下:低危≤3.4 log、3.4 log 5.7 log。在训练队列和外部验证队列中,ADV 评分预测高危组(第 3 组)的灵敏度分别为 70.2%(99/141)和 78.8%(63/80):ADV评分的临界值为5.7 log,它可能成为筛查HCC复发高危患者的重要指标,有助于外科医生、病理学家和HCC患者做出适当的临床决策。
{"title":"Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study.","authors":"Shuya Cao, Zheyu Zhou, Chaobo Chen, Wenwen Li, Jinsong Liu, Jiawei Xu, Chunlong Zhao, Yihang Yuan, Zhenggang Xu, Huaiyu Wu, Guwei Ji, Xiaoliang Xu, Ke Wang","doi":"10.1186/s12957-024-03523-1","DOIUrl":"https://doi.org/10.1186/s12957-024-03523-1","url":null,"abstract":"<p><strong>Background: </strong>Postoperative recurrence is a vital reason for poor 5-year overall survival in hepatocellular carcinoma (HCC) patients. The ADV score is considered a parameter that can quantify HCC aggressiveness. This study aimed to identify HCC patients at high-risk of recurrence early using the ADV score.</p><p><strong>Methods: </strong>The medical data of consecutive HCC patients undergoing hepatectomy from The First Affiliated Hospital of Nanjing Medical University (TFAHNJMU) and Nanjing Drum Tower Hospital (NJDTH) were retrospectively reviewed. Based on the status of microvascular invasion and the Edmondson-Steiner grade, HCC patients were divided into three groups: low-risk group (group 1: no risk factor exists), medium-risk group (group 2: one risk factor exists), and high-risk group (group 3: coexistence of two risk factors). In the training cohort (TFAHNJMU), the R package nnet was used to establish a multi-categorical unordered logistic regression model based on the ADV score to predict three risk groups. The Welch's T-test was used to compare differences in clinical variables in three predicted risk groups. NJDTH served as an external validation center. At last, the confusion matrix was developed using the R package caret to evaluate the diagnostic performance of the model.</p><p><strong>Results: </strong>350 and 405 patients from TFAHNJMU and NJDTH were included. HCC patients in different risk groups had significantly different liver function and inflammation levels. Density maps demonstrated that the ADV score could best differentiate between the three risk groups. The probability curve was plotted according to the predicted results of the multi-categorical unordered logistic regression model, and the best cut-off values of the ADV score were as follows: low-risk ≤ 3.4 log, 3.4 log < medium-risk ≤ 5.7 log, and high-risk > 5.7 log. The sensitivities of the ADV score predicting the high-risk group (group 3) were 70.2% (99/141) and 78.8% (63/80) in the training and external validation cohort, respectively.</p><p><strong>Conclusion: </strong>The ADV score might become a valuable marker for screening patients at high-risk of HCC recurrence with a cut-off value of 5.7 log, which might help surgeons, pathologists, and HCC patients make appropriate clinical decisions.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful modified CLEAN-NET with semicircular seromuscular layer incision for a gastric GIST near the cardia: a case report and video demonstration. 用半圆形蚕膜层切口成功切除贲门附近的胃腺体囊肿:病例报告和视频演示。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-06 DOI: 10.1186/s12957-024-03528-w
Hitoshi Hara, Seito Shimizu, Yasuhide Muto, Tomoki Kido, Ryohei Miyata, Moe Tokuda, Kyuichiro Takahashi, Tomohiro Maesono, Takahiro Ajihara, Aki Yagi, Takuma Naritomi, Michio Itabashi

Background: The combination of laparoscopic and endoscopic approaches to neoplasia with a non-exposure technique (CLEAN-NET) is a laparoscopic and endoscopic cooperative surgery (LECS). It combines laparoscopic gastric resection and endoscopic techniques for local resection of gastric tumors, such as gastrointestinal stromal tumors (GIST), with minimal surgical margins. A conventional CLEAN-NET surgical procedure is complex, requiring careful techniques to preserve the cardia, particularly in case of nearby lesions. We describe the case of a patient who underwent a modified CLEAN-NET approach with a semi-circular seromuscular layer incision surrounding the base of the tumor, different from a circular shape seromuscular layer in the conventional CLEAN-NET: around the tumor to preserve mucosal continuity, which acts as a barrier to avoid intraoperative tumor dissemination.

Case presentation: A 43-year-old woman was referred to our hospital because of a gastric submucosal tumor near the cardia, detected on medical examination. The patient was diagnosed with gastric GIST based on the results of endoscopic ultrasound-guided fine-needle aspiration. Modified CLEAN-NET was performed with a semicircular incision of the seromuscular layer on the opposite side of the cardia, making the surgical procedure simple and minimizing partial resection of the gastric wall, including the tumor, while preserving the cardia. The operative time was 147 min, preoperative blood loss volume was 3 mL, and postoperative hospital stay was 9 days. The resected specimen revealed a minimal resection of the gastric wall, including the tumor. The cardia and gastric nerves were preserved, and the postoperative food intake was good.

Conclusions: The modified CLEAN-NET with semicircular seromuscular layer dissection is a simple and reliable surgical procedure for GIST near the cardia.

背景:结合腹腔镜和内镜方法治疗肿瘤的无暴露技术(CLEAN-NET)是一种腹腔镜和内镜合作手术(LECS)。它结合了腹腔镜胃切除术和内镜技术,用于胃肿瘤(如胃肠道间质瘤(GIST))的局部切除,手术切缘最小。传统的 CLEAN-NET 手术过程非常复杂,需要小心翼翼地保留贲门,尤其是在附近有病灶的情况下。我们描述了一例采用改良CLEAN-NET方法的患者的病例,该方法采用围绕肿瘤底部的半圆形血清肌层切口,不同于传统CLEAN-NET的圆形血清肌层切口:肿瘤周围保留粘膜连续性,作为避免术中肿瘤扩散的屏障:一名 43 岁的女性因体检发现贲门附近有胃黏膜下肿瘤而转诊至我院。根据内镜超声引导下细针穿刺的结果,患者被诊断为胃 GIST。改良的CLEAN-NET手术在贲门对侧的浆肌层做半圆形切口,使手术过程简单,并在保留贲门的同时,最大限度地减少了对胃壁(包括肿瘤)的部分切除。手术时间为147分钟,术前失血量为3毫升,术后住院9天。切除的标本显示,包括肿瘤在内的胃壁得到了最小程度的切除。保留了贲门和胃神经,术后进食情况良好:结论:改良的CLEAN-NET半圆形浆肌层剥离术是治疗贲门附近GIST的一种简单可靠的手术方法。
{"title":"Successful modified CLEAN-NET with semicircular seromuscular layer incision for a gastric GIST near the cardia: a case report and video demonstration.","authors":"Hitoshi Hara, Seito Shimizu, Yasuhide Muto, Tomoki Kido, Ryohei Miyata, Moe Tokuda, Kyuichiro Takahashi, Tomohiro Maesono, Takahiro Ajihara, Aki Yagi, Takuma Naritomi, Michio Itabashi","doi":"10.1186/s12957-024-03528-w","DOIUrl":"10.1186/s12957-024-03528-w","url":null,"abstract":"<p><strong>Background: </strong>The combination of laparoscopic and endoscopic approaches to neoplasia with a non-exposure technique (CLEAN-NET) is a laparoscopic and endoscopic cooperative surgery (LECS). It combines laparoscopic gastric resection and endoscopic techniques for local resection of gastric tumors, such as gastrointestinal stromal tumors (GIST), with minimal surgical margins. A conventional CLEAN-NET surgical procedure is complex, requiring careful techniques to preserve the cardia, particularly in case of nearby lesions. We describe the case of a patient who underwent a modified CLEAN-NET approach with a semi-circular seromuscular layer incision surrounding the base of the tumor, different from a circular shape seromuscular layer in the conventional CLEAN-NET: around the tumor to preserve mucosal continuity, which acts as a barrier to avoid intraoperative tumor dissemination.</p><p><strong>Case presentation: </strong>A 43-year-old woman was referred to our hospital because of a gastric submucosal tumor near the cardia, detected on medical examination. The patient was diagnosed with gastric GIST based on the results of endoscopic ultrasound-guided fine-needle aspiration. Modified CLEAN-NET was performed with a semicircular incision of the seromuscular layer on the opposite side of the cardia, making the surgical procedure simple and minimizing partial resection of the gastric wall, including the tumor, while preserving the cardia. The operative time was 147 min, preoperative blood loss volume was 3 mL, and postoperative hospital stay was 9 days. The resected specimen revealed a minimal resection of the gastric wall, including the tumor. The cardia and gastric nerves were preserved, and the postoperative food intake was good.</p><p><strong>Conclusions: </strong>The modified CLEAN-NET with semicircular seromuscular layer dissection is a simple and reliable surgical procedure for GIST near the cardia.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of omentum preservation on long-term prognosis of locally advanced gastric cancer: a systematic review and meta-analysis. 保留网膜对局部晚期胃癌长期预后的影响:系统回顾和荟萃分析。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-06 DOI: 10.1186/s12957-024-03521-3
Xiaoshuai Zhou, Wentao Sheng, Tongmin Huang, Wei Ren

Background: The effect of omentum preservation (OP) on locally advanced gastric cancer (LAGC) remains controversial. This study aimed to investigate the long-term prognosis of LAGC patients with OP versus omentum resection (OR).

Methods: A comprehensive search of databases including PubMed, Web of Science, Embase, and Cochrane Library was conducted up until February 2024. Statistical analysis was performed using Stata 12.0 software. The primary outcome was to assess the impact of OP on the long-term prognosis of patients with LAGC, including overall survival (OS) and recurrence-free survival (RFS).

Results: A total of six case-control studies were included, encompassing a cohort of 1897 patients. The OP group consisted of 844 patients, while the OR group comprised 1053 patients. The study results showed that the OS (HR = 0.72, 95% CI: 0.58-0.90, P = 0.003) and 5-year RFS (HR = 0.79, 95% CI: 0.63-0.99, P = 0.038) in the OP group were superior to those observed in the OR group. Subgroup analysis indicated that 5-year OS (HR = 0.64, P = 0.003) and 5-year RFS (HR = 0.69, P = 0.005) in the OP group were also better than those in the OR group in Korea. However, the subgroup analysis conducted on stage T3-T4 tumors revealed no statistically significant differences in OS (P = 0.083) and 5-year RFS (P = 0.173) between the two groups.

Conclusion: Compared with OR, OP shows non-inferiority in patients with LAGC and can be considered a potential treatment option for radical gastrectomy.

背景:保留网膜(OP)对局部晚期胃癌(LAGC)的影响仍存在争议。本研究旨在探讨保留网膜手术(OP)与网膜切除术(OR)对局部晚期胃癌患者长期预后的影响:截至 2024 年 2 月,对包括 PubMed、Web of Science、Embase 和 Cochrane Library 在内的数据库进行了全面检索。统计分析使用 Stata 12.0 软件进行。主要结果是评估 OP 对 LAGC 患者长期预后的影响,包括总生存期(OS)和无复发生存期(RFS):结果:共纳入了六项病例对照研究,包括 1897 例患者。OP组有844名患者,OR组有1053名患者。研究结果显示,OP 组的 OS(HR = 0.72,95% CI:0.58-0.90,P = 0.003)和 5 年 RFS(HR = 0.79,95% CI:0.63-0.99,P = 0.038)优于 OR 组。亚组分析表明,在韩国,OP 组的 5 年 OS(HR = 0.64,P = 0.003)和 5 年 RFS(HR = 0.69,P = 0.005)也优于 OR 组。然而,对T3-T4期肿瘤进行的亚组分析显示,两组的OS(P = 0.083)和5年RFS(P = 0.173)差异无统计学意义:结论:与 OR 相比,OP 在 LAGC 患者中显示出非劣势,可视为根治性胃切除术的一种潜在治疗方案。
{"title":"Effect of omentum preservation on long-term prognosis of locally advanced gastric cancer: a systematic review and meta-analysis.","authors":"Xiaoshuai Zhou, Wentao Sheng, Tongmin Huang, Wei Ren","doi":"10.1186/s12957-024-03521-3","DOIUrl":"10.1186/s12957-024-03521-3","url":null,"abstract":"<p><strong>Background: </strong>The effect of omentum preservation (OP) on locally advanced gastric cancer (LAGC) remains controversial. This study aimed to investigate the long-term prognosis of LAGC patients with OP versus omentum resection (OR).</p><p><strong>Methods: </strong>A comprehensive search of databases including PubMed, Web of Science, Embase, and Cochrane Library was conducted up until February 2024. Statistical analysis was performed using Stata 12.0 software. The primary outcome was to assess the impact of OP on the long-term prognosis of patients with LAGC, including overall survival (OS) and recurrence-free survival (RFS).</p><p><strong>Results: </strong>A total of six case-control studies were included, encompassing a cohort of 1897 patients. The OP group consisted of 844 patients, while the OR group comprised 1053 patients. The study results showed that the OS (HR = 0.72, 95% CI: 0.58-0.90, P = 0.003) and 5-year RFS (HR = 0.79, 95% CI: 0.63-0.99, P = 0.038) in the OP group were superior to those observed in the OR group. Subgroup analysis indicated that 5-year OS (HR = 0.64, P = 0.003) and 5-year RFS (HR = 0.69, P = 0.005) in the OP group were also better than those in the OR group in Korea. However, the subgroup analysis conducted on stage T3-T4 tumors revealed no statistically significant differences in OS (P = 0.083) and 5-year RFS (P = 0.173) between the two groups.</p><p><strong>Conclusion: </strong>Compared with OR, OP shows non-inferiority in patients with LAGC and can be considered a potential treatment option for radical gastrectomy.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11378409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term outcomes of Transrectal Natural Orifice Specimen extraction compared with conventional minimally invasive surgery for selected patients with colorectal cancer: a propensity score matching analysis and literature review. 经直肠自然孔道标本提取术与传统微创手术对部分结直肠癌患者的短期疗效比较:倾向得分匹配分析和文献综述。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-06 DOI: 10.1186/s12957-024-03513-3
Li-Yang Chan, Yih-Jong Chern, Yu-Jen Hsu, Bor-Kang Jong, I-Li Lai, Pao-Shiu Hsieh, Chun-Kai Liao, Jeng-Fu You

Purpose: Conventional minimally invasive surgery requires mini-laparotomy to extract the pathological specimen. However, by using a natural orifice as the delivery route, natural orifice specimen extraction (NOSE) surgery avoids the need for a large incision. This study analyzed the short-term outcome of NOSE compared with conventional mini-laparotomy (CL) for colorectal cancer surgery.

Methods: We conducted a retrospective analysis of 1,189 patients who underwent surgery for primary colorectal cancer between the cecum and upper rectum. Propensity score analyses were applied to the NOSE and CL groups in a 1:1 matched cohort.

Results: After propensity score matching, each group included 201 patients. The NOSE group and CL group did not differ significantly in terms of baseline characteristics. Postoperative morbidity and mortality rates were comparable. Compared with the CL group, the NOSE group experienced a shorter time to first flatus (1.6 ± 0.8 vs. 2.0 ± 1.2 days, p < 0.001), first stool (2.7 ± 1.5 vs. 4.1 ± 1.9, p < 0.001), liquid diet (2.3 ± 1.3 vs. 3.6 ± 1.8 days, p < 0.001), soft diet (3.9 ± 2.0 vs. 5.2 ± 1.9 days, p < 0.001) and a shorter hospital stay (5.1 ± 3.5 vs. 7.4 ± 4.8 days, p < 0.001). The NOSE group exhibited lower mean pain intensity and lower highest pain intensity on postoperative days 1, 2, and 3.

Conclusion: NOSE has several advantages over conventional mini-laparotomy following minimally invasive surgery for colon cancer. These advantages include reduced time to oral intake, shorter hospital stays, and less postoperative pain. NOSE can be adopted and applied to highly selective patients without additional risk of short-term complications.

目的:传统的微创手术需要小切口来提取病理标本。然而,通过使用自然孔口作为输送路径,自然孔口标本提取(NOSE)手术避免了大切口的需要。本研究分析了 NOSE 与传统小切口(CL)结直肠癌手术相比的短期疗效:我们对 1,189 名在盲肠和直肠上段之间接受原发性结直肠癌手术的患者进行了回顾性分析。对 1:1 匹配队列中的 NOSE 组和 CL 组进行倾向得分分析:结果:倾向得分匹配后,每组包括 201 名患者。NOSE组和CL组在基线特征方面没有显著差异。术后发病率和死亡率相当。与 CL 组相比,NOSE 组首次排气时间更短(1.6±0.8 天 vs. 2.0±1.2 天,P 结论:NOSE 比 CL 组具有更多优势:与传统的结肠癌微创手术小切口相比,NOSE 具有多项优势。这些优势包括缩短口服时间、缩短住院时间和减轻术后疼痛。NOSE 可用于高选择性患者,不会增加短期并发症的风险。
{"title":"Short-term outcomes of Transrectal Natural Orifice Specimen extraction compared with conventional minimally invasive surgery for selected patients with colorectal cancer: a propensity score matching analysis and literature review.","authors":"Li-Yang Chan, Yih-Jong Chern, Yu-Jen Hsu, Bor-Kang Jong, I-Li Lai, Pao-Shiu Hsieh, Chun-Kai Liao, Jeng-Fu You","doi":"10.1186/s12957-024-03513-3","DOIUrl":"10.1186/s12957-024-03513-3","url":null,"abstract":"<p><strong>Purpose: </strong>Conventional minimally invasive surgery requires mini-laparotomy to extract the pathological specimen. However, by using a natural orifice as the delivery route, natural orifice specimen extraction (NOSE) surgery avoids the need for a large incision. This study analyzed the short-term outcome of NOSE compared with conventional mini-laparotomy (CL) for colorectal cancer surgery.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of 1,189 patients who underwent surgery for primary colorectal cancer between the cecum and upper rectum. Propensity score analyses were applied to the NOSE and CL groups in a 1:1 matched cohort.</p><p><strong>Results: </strong>After propensity score matching, each group included 201 patients. The NOSE group and CL group did not differ significantly in terms of baseline characteristics. Postoperative morbidity and mortality rates were comparable. Compared with the CL group, the NOSE group experienced a shorter time to first flatus (1.6 ± 0.8 vs. 2.0 ± 1.2 days, p < 0.001), first stool (2.7 ± 1.5 vs. 4.1 ± 1.9, p < 0.001), liquid diet (2.3 ± 1.3 vs. 3.6 ± 1.8 days, p < 0.001), soft diet (3.9 ± 2.0 vs. 5.2 ± 1.9 days, p < 0.001) and a shorter hospital stay (5.1 ± 3.5 vs. 7.4 ± 4.8 days, p < 0.001). The NOSE group exhibited lower mean pain intensity and lower highest pain intensity on postoperative days 1, 2, and 3.</p><p><strong>Conclusion: </strong>NOSE has several advantages over conventional mini-laparotomy following minimally invasive surgery for colon cancer. These advantages include reduced time to oral intake, shorter hospital stays, and less postoperative pain. NOSE can be adopted and applied to highly selective patients without additional risk of short-term complications.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of postoperative analgesia by thoracoscopic-guided thoracic paravertebral block and thoracoscopic-guided intercostal nerve block in uniportal video-asssited thoracic surgery: a prospective randomized controlled trial. 单孔视频旁路胸外科手术中胸腔镜引导下胸椎旁阻滞术与胸腔镜引导下肋间神经阻滞术的术后镇痛比较:一项前瞻性随机对照试验。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-06 DOI: 10.1186/s12957-024-03517-z
Xia Xu, Meng Zhang, Yan Li, Jian-Hui Du, Jin-Xian He, Li-Hong Hu

Background: Thoracoscopic-guided thoracic paravertebral nerve block (TG-TPVB) and thoracoscopic-guided intercostal nerve block (TG-INB) are two postoperative analgesia technology for thoracic surgery. This study aims to compared the analgesic effect of TG-TPVB and TG-INB after uniportal video-asssited thoracic surgery (UniVATS).

Methods: Fifty-eight patients were randomly allocated to the TG-TPVB group and the TG-INB group. The surgical time of nerve block, the visual analog scale (VAS) scores, the consumption of sufentanil and the number of patient-controlled intravenous analgesic (PCIA) presses within 24 h after surgery, the incidence of adverse reactions were compared between the two groups.

Results: The VAS scores were significantly lower during rest and coughing at 2, 6, 12, and 24 h in the TG-TPVB group than in the TG-INB group (P < 0.05). The consumption of sufentanil and the number of PCIA presses within 24 h after surgery were significantly lower in the TG-TPVB group than in the TG-INB group (P < 0.001).The surgical time of nerve block was significantly shorter in the TG-TPVB group than in the TG-INB group (P < 0.001). The incidence of bleeding at the puncture point was lower in the TG-TPVB group than that in the TG-INB group (P < 0.05).

Conclusion: TG-TPVB demonstrated superior acute pain relieve after uniVATS, shorter surgical time and non-inferior adverse effects than TG-INB.

背景:胸腔镜引导下胸椎旁神经阻滞(TG-TPVB)和胸腔镜引导下肋间神经阻滞(TG-INB)是胸外科手术的两种术后镇痛技术。本研究旨在比较单孔视频辅助胸腔镜手术(UniVATS)后 TG-TPVB 和 TG-INB 的镇痛效果:58名患者被随机分配到TG-TPVB组和TG-INB组。比较两组患者的神经阻滞手术时间、视觉模拟量表(VAS)评分、舒芬太尼用量、术后 24 小时内患者自控静脉镇痛剂(PCIA)按压次数、不良反应发生率:结果:TG-TPVB 组在休息和咳嗽时的 VAS 评分在 2、6、12 和 24 小时内均明显低于 TG-INB 组(P与 TG-INB 相比,TG-TPVB 能更好地缓解 uniVATS 后的急性疼痛,手术时间更短,不良反应更少。
{"title":"Comparison of postoperative analgesia by thoracoscopic-guided thoracic paravertebral block and thoracoscopic-guided intercostal nerve block in uniportal video-asssited thoracic surgery: a prospective randomized controlled trial.","authors":"Xia Xu, Meng Zhang, Yan Li, Jian-Hui Du, Jin-Xian He, Li-Hong Hu","doi":"10.1186/s12957-024-03517-z","DOIUrl":"10.1186/s12957-024-03517-z","url":null,"abstract":"<p><strong>Background: </strong>Thoracoscopic-guided thoracic paravertebral nerve block (TG-TPVB) and thoracoscopic-guided intercostal nerve block (TG-INB) are two postoperative analgesia technology for thoracic surgery. This study aims to compared the analgesic effect of TG-TPVB and TG-INB after uniportal video-asssited thoracic surgery (UniVATS).</p><p><strong>Methods: </strong>Fifty-eight patients were randomly allocated to the TG-TPVB group and the TG-INB group. The surgical time of nerve block, the visual analog scale (VAS) scores, the consumption of sufentanil and the number of patient-controlled intravenous analgesic (PCIA) presses within 24 h after surgery, the incidence of adverse reactions were compared between the two groups.</p><p><strong>Results: </strong>The VAS scores were significantly lower during rest and coughing at 2, 6, 12, and 24 h in the TG-TPVB group than in the TG-INB group (P < 0.05). The consumption of sufentanil and the number of PCIA presses within 24 h after surgery were significantly lower in the TG-TPVB group than in the TG-INB group (P < 0.001).The surgical time of nerve block was significantly shorter in the TG-TPVB group than in the TG-INB group (P < 0.001). The incidence of bleeding at the puncture point was lower in the TG-TPVB group than that in the TG-INB group (P < 0.05).</p><p><strong>Conclusion: </strong>TG-TPVB demonstrated superior acute pain relieve after uniVATS, shorter surgical time and non-inferior adverse effects than TG-INB.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes. 术后辅助治疗对表皮生长因子受体(EGFR)突变的IA期微乳头状病理亚型肺腺癌的影响
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-05 DOI: 10.1186/s12957-024-03429-y
Ran Cheng, Zhexue Hao, Li Qiu, Xiang Zheng, Sihe Huang, Jianzhao Xian, Haoyang Huang, Jianfu Li, Zhenhui Zhang, Kaiwen Ye, Wentao Wu, Yaowen Zhang, Jun Liu

Background: Micropapillary (MPP) adenocarcinoma is considered one of the most aggressive pathological types of lung adenocarcinoma (LADC). This retrospective study aimed to evaluate the prognostic significance and benefit of postoperative adjuvant therapy (PAT) in stage IA LADC patients with different proportions of MPP components.

Materials and methods: We retrospectively examined clinical stage IA LADC patients who underwent surgical resection between August 2012 and December 2019. In terms of the proportion of MPP components (TPM), the tumors were reclassified into three categories: MPP patterns absent (TPMN); low proportions of MPP components (TPML); and high proportions of MPP components (TPMH). The dates of recurrence and metastasis were identified based on physical examinations and were confirmed by histopathological examination.

Results: Overall, 505 (TPMN, n = 375; TPML, n = 92; TPMH, n = 38) patients harboring EGFR mutations were enrolled in the study. Male sex (P = 0.044), high pathological stage (P < 0.001), and MPP pathological subtype (P < 0.001) were more frequent in the TPM-positive (TPMP) group than in the TPM-negative (TPMN) group. Five-year disease-free survival (DFS) rates were significantly lower in the TPMP group than in the TPMN group (84.5% vs. 93.4%, P = 0.006). In addition, patients with high proportions (greater than 10%) of MPP components had worse overall survival (OS) (91.0% vs. 98.9%, P = 0.025) than those with low proportions (5%≤ TPM ≤ 10%). However, postoperative EGFR tyrosine kinase inhibitors (TKIs) or adjuvant chemotherapy (ACT) cannot improve DFS and OS between EGFR-mutated patients with different proportions of MPP components.

Conclusion: MPP was related to earlier recurrence and shortened survival time, even in stage IA. Further research needs a larger sample size to clarify that EGFR-mutated stage IA patients with MPP components obtain survival benefits from adjuvant therapy.

背景:微乳头状腺癌(MPP)被认为是肺腺癌(LADC)中最具侵袭性的病理类型之一。这项回顾性研究旨在评估不同MPP成分比例的IA期LADC患者的预后意义和术后辅助治疗(PAT)的益处:我们回顾性研究了2012年8月至2019年12月期间接受手术切除的临床IA期LADC患者。根据MPP成分(TPM)的比例,将肿瘤重新分为三类:MPP模式缺失(TPMN);MPP成分比例低(TPML);MPP成分比例高(TPMH)。根据体格检查确定复发和转移日期,并通过组织病理学检查加以确认:共有505例(TPMN,375例;TPML,92例;TPMH,38例)表皮生长因子受体突变患者参与研究。男性(P = 0.044)、高病理分期(P 结论:MPP与较早复发有关:即使是IA期患者,MPP也与较早复发和生存时间缩短有关。进一步的研究需要更大的样本量,以明确有MPP成分的表皮生长因子受体突变IA期患者是否能从辅助治疗中获益。
{"title":"The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes.","authors":"Ran Cheng, Zhexue Hao, Li Qiu, Xiang Zheng, Sihe Huang, Jianzhao Xian, Haoyang Huang, Jianfu Li, Zhenhui Zhang, Kaiwen Ye, Wentao Wu, Yaowen Zhang, Jun Liu","doi":"10.1186/s12957-024-03429-y","DOIUrl":"10.1186/s12957-024-03429-y","url":null,"abstract":"<p><strong>Background: </strong>Micropapillary (MPP) adenocarcinoma is considered one of the most aggressive pathological types of lung adenocarcinoma (LADC). This retrospective study aimed to evaluate the prognostic significance and benefit of postoperative adjuvant therapy (PAT) in stage IA LADC patients with different proportions of MPP components.</p><p><strong>Materials and methods: </strong>We retrospectively examined clinical stage IA LADC patients who underwent surgical resection between August 2012 and December 2019. In terms of the proportion of MPP components (TPM), the tumors were reclassified into three categories: MPP patterns absent (TPMN); low proportions of MPP components (TPML); and high proportions of MPP components (TPMH). The dates of recurrence and metastasis were identified based on physical examinations and were confirmed by histopathological examination.</p><p><strong>Results: </strong>Overall, 505 (TPMN, n = 375; TPML, n = 92; TPMH, n = 38) patients harboring EGFR mutations were enrolled in the study. Male sex (P = 0.044), high pathological stage (P < 0.001), and MPP pathological subtype (P < 0.001) were more frequent in the TPM-positive (TPMP) group than in the TPM-negative (TPMN) group. Five-year disease-free survival (DFS) rates were significantly lower in the TPMP group than in the TPMN group (84.5% vs. 93.4%, P = 0.006). In addition, patients with high proportions (greater than 10%) of MPP components had worse overall survival (OS) (91.0% vs. 98.9%, P = 0.025) than those with low proportions (5%≤ TPM ≤ 10%). However, postoperative EGFR tyrosine kinase inhibitors (TKIs) or adjuvant chemotherapy (ACT) cannot improve DFS and OS between EGFR-mutated patients with different proportions of MPP components.</p><p><strong>Conclusion: </strong>MPP was related to earlier recurrence and shortened survival time, even in stage IA. Further research needs a larger sample size to clarify that EGFR-mutated stage IA patients with MPP components obtain survival benefits from adjuvant therapy.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142133941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on survival of sarcopenia, systemic inflammatory response and anthropometric factors after pancreatectomy for resectable pancreatic adenocarcinoma. 可切除胰腺腺癌胰腺切除术后,肌肉疏松症、全身炎症反应和人体测量因素对存活率的影响。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-09-04 DOI: 10.1186/s12957-024-03510-6
Kaja Balcer, Jonathan Garnier, Yasmina Richa, Christophe Bruneel-Zupanc, Guillaume Piessen, Olivier Turrini, Stephanie Truant, Mehdi El Amrani

Introduction: Pancreatic adenocarcinoma (PDAC) is becoming a public health issue with a 5-years survival rate around 10%. Patients with PDAC are often sarcopenic, which impacts postoperative outcome. At the same time, overweight population is increasing and adipose tissue promotes tumor related-inflammation. With several studies supporting independently these data, we aimed to assess if they held an impact on survival when combined.

Methods: We included 232 patients from two university hospitals (CHU de Lille, Institut Paoli Calmette), from January 2011 to December 2018, who underwent Pancreaticoduodenectomy (PD) for resectable PDAC. Preoperative CT scan was used to measure sarcopenia and visceral fat according to international cut-offs. Neutrophil to lymphocyte (NLR) and platelet to lymphocyte ratios (PLR) were used to measure inflammation. For univariate and multivariate analyses, the Cox proportional-hazard model was used. P-values below 0.05 were considered significant.

Results: Sarcopenic patients with visceral obesity were less likely to survive than the others in multivariate analysis (OS, HR 1.65, p= 0.043). Cutaneous obesity did not influence survival. We also observed an influence on survival when we studied sarcopenia with visceral obesity (OS, p= 0.056; PFS, p = 0.014), sarcopenia with cutaneous obesity (PFS, p= 0.005) and sarcopenia with PLR (PFS, p= 0.043). This poor prognosis was also found in sarcopenic obese patients with high PLR (OS, p= 0.05; PFS, p= 0.01).

Conclusion: Sarcopenic obesity was associated with poor prognosis after PD for PDAC, especially in patients with systemic inflammation. Pre operative management of these factors should be addressed in pancreatic cancer patients.

简介胰腺腺癌(PDAC)正成为一个公共卫生问题,其 5 年生存率约为 10%。PDAC 患者通常肌肉松弛,影响术后效果。与此同时,超重人群正在增加,脂肪组织会促进与肿瘤相关的炎症。有几项研究独立地支持这些数据,我们的目的是评估当这些数据结合在一起时是否会对生存率产生影响:我们纳入了 2011 年 1 月至 2018 年 12 月期间来自两所大学医院(里尔中央医院、保利卡尔梅特研究所)的 232 名患者,他们都因可切除的 PDAC 而接受了胰十二指肠切除术(PD)。术前 CT 扫描用于根据国际截断值测量肌少症和内脏脂肪。中性粒细胞与淋巴细胞比率(NLR)和血小板与淋巴细胞比率(PLR)用于测量炎症。单变量和多变量分析采用 Cox 比例危险模型。P值低于0.05为显著:结果:在多变量分析中,内脏肥胖的肢端肥大症患者存活率低于其他患者(OS,HR 1.65,P= 0.043)。皮肤肥胖不影响存活率。当我们研究肌肉疏松症合并内脏肥胖(OS,p= 0.056;PFS,p= 0.014)、肌肉疏松症合并皮肤肥胖(PFS,p= 0.005)和肌肉疏松症合并 PLR(PFS,p= 0.043)时,我们也观察到这些患者的存活率受到影响。高PLR的肌肉疏松性肥胖患者的预后也较差(OS,p= 0.05;PFS,p= 0.01):结论:肌肉松弛性肥胖与PDAC腹腔镜手术后的不良预后有关,尤其是伴有全身炎症的患者。胰腺癌患者术前应注意控制这些因素。
{"title":"Impact on survival of sarcopenia, systemic inflammatory response and anthropometric factors after pancreatectomy for resectable pancreatic adenocarcinoma.","authors":"Kaja Balcer, Jonathan Garnier, Yasmina Richa, Christophe Bruneel-Zupanc, Guillaume Piessen, Olivier Turrini, Stephanie Truant, Mehdi El Amrani","doi":"10.1186/s12957-024-03510-6","DOIUrl":"10.1186/s12957-024-03510-6","url":null,"abstract":"<p><strong>Introduction: </strong>Pancreatic adenocarcinoma (PDAC) is becoming a public health issue with a 5-years survival rate around 10%. Patients with PDAC are often sarcopenic, which impacts postoperative outcome. At the same time, overweight population is increasing and adipose tissue promotes tumor related-inflammation. With several studies supporting independently these data, we aimed to assess if they held an impact on survival when combined.</p><p><strong>Methods: </strong>We included 232 patients from two university hospitals (CHU de Lille, Institut Paoli Calmette), from January 2011 to December 2018, who underwent Pancreaticoduodenectomy (PD) for resectable PDAC. Preoperative CT scan was used to measure sarcopenia and visceral fat according to international cut-offs. Neutrophil to lymphocyte (NLR) and platelet to lymphocyte ratios (PLR) were used to measure inflammation. For univariate and multivariate analyses, the Cox proportional-hazard model was used. P-values below 0.05 were considered significant.</p><p><strong>Results: </strong>Sarcopenic patients with visceral obesity were less likely to survive than the others in multivariate analysis (OS, HR 1.65, p= 0.043). Cutaneous obesity did not influence survival. We also observed an influence on survival when we studied sarcopenia with visceral obesity (OS, p= 0.056; PFS, p = 0.014), sarcopenia with cutaneous obesity (PFS, p= 0.005) and sarcopenia with PLR (PFS, p= 0.043). This poor prognosis was also found in sarcopenic obese patients with high PLR (OS, p= 0.05; PFS, p= 0.01).</p><p><strong>Conclusion: </strong>Sarcopenic obesity was associated with poor prognosis after PD for PDAC, especially in patients with systemic inflammation. Pre operative management of these factors should be addressed in pancreatic cancer patients.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142133936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of Surgical Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1